Clinical Trial

Integrating Molecular Pathology, Radiology, and Genetics to Improve Breast Cancer Risk

Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this research is to better understand how benign breast diseases might lead to breast cancer, focusing on genetic factors and including a diverse range of participants to improve future diagnosis and treatment.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-09-26; most recent amendment 2026-03-11.
Trial Details
NCT Number NCT07207564
Lead Sponsor Mayo Clinic
Conditions Breast Carcinoma
Enrollment 4,500 participants
Start Date 2025-08-28
Primary Completion 2030-06-30 (estimated)
Study Completion 2030-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-03-13